Recent News

• 04.22.2025 - Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call
• 03.31.2025 - Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
• 03.27.2025 - Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
• 03.04.2025 - Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
• 03.03.2025 - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 04.10.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.10.2025 - DEF 14A Other definitive proxy statements
• 03.27.2025 - PRE 14A Other preliminary proxy statements
• 03.27.2025 - 8-K/A Current report
• 03.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2025 - 4/A Statement of changes in beneficial ownership of securities
• 03.13.2025 - 4/A Statement of changes in beneficial ownership of securities
• 03.13.2025 - 4/A Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities